Interestingly, the combination therapy of liraglutide (a glucagon-like peptide 1 [GLP-1] analogue) and anti-IL-21 antibody resulted in enhanced C-peptide secretion over 54 weeks in adults with recent-onset type 1 diabetes [10]. Here, GCG is linked to type 1 diabetes mellitus.